By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Rules-Based Medicine today said that it has acquired intellectual property assets covering biomarker technology from Satoris.

The deal includes biomarkers and biomarker panels for clinical research use for Alzheimer's disease, frontal temporal dementia, Parkinson's disease, and other central nervous system conditions.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genomic study of group B Streptococcus evolution, selection on the X chromosome in great apes, and more.

Changing the fat and fiber content of people's diets affects their gut microbiome, metabolome, and colon cancer risk, researchers say.

Broken links are found throughout academic publications, and some services are trying to combat such link decay.

Nick Stockton at Wired says that a pause in studying genome-editing tools should be used to find a path forward.